alpidem has been researched along with Schizophrenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inada, K; Iwata, N; Kishi, T; Matsui, Y | 1 |
| Cesana, B; Farolfi, A; Minervini, MG; Morselli, PL; Priore, P | 1 |
1 review(s) available for alpidem and Schizophrenia
| Article | Year |
|---|---|
Z-drug for schizophrenia: A systematic review and meta-analysis.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Eszopiclone; Female; Humans; Hypnotics and Sedatives; Imidazoles; Male; Middle Aged; Pyridines; Randomized Controlled Trials as Topic; Schizophrenia; Sleep; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Young Adult | 2017 |
1 trial(s) available for alpidem and Schizophrenia
| Article | Year |
|---|---|
Double blind, controlled study of the efficacy and safety of alpidem in the treatment of anxiety in schizophrenic in-patients.
Topics: Adult; Aged; Anti-Anxiety Agents; Anxiety; Double-Blind Method; Female; Humans; Imidazoles; Male; Middle Aged; Psychiatric Status Rating Scales; Pyridines; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology | 1990 |